Manufacturer of Controlled Substances Notice of Application, 36681 [2010-15517]

Download as PDF 36681 Federal Register / Vol. 75, No. 123 / Monday, June 28, 2010 / Notices DEPARTMENT OF JUSTICE Drug Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Application Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 29, 2010, Alltech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: jlentini on DSKJ8SOYB1PROD with NOTICES Drug Schedule Methcathinone (1237) .................. N-ethylamphetamine (1475) ......... N,N-dimethylamphetamine (1480) 4-methylaminorex (cis isomer) (1590). Alpha-ethyltryptamine (7249) ....... Lysergic acid diethylamide (7315) 4-methylaminorex (cis isomer) (1590). Alpha-ethyltryptamine (7249) ....... Lysergic acid diethylamide (7315) 2,5-dimethoxy-4-(n)propylthiophenethylamine (7348). Tetrahydrocannabinols (7370) ..... Mescaline (7381) .......................... 4-bromo-2,5-dimethoxy-amphetamine (7391). 4–Bromo-2,5dimethoxyphenethylamine (7392). 4-methyl-2,5-dimethoxy-amphetamine (7395). 2,5-dimethoxyamphetamine (7396). 2,5-dimethoxy-4ethylamphetamine (7399). 3,4-methylenedioxy amphetamine (7400). N-hydroxy-3,4methylenedioxyamphetamine (7402). 3,4-methylenedioxy-Nethylamphetamine (7404). 3,4methylenedioxymethamphetamine (MDMA) (7405). 4-methoxyamphetamine (7411) ... Alpha-methyltryptamine (7432) .... Bufotenine (7433) ......................... Diethyltryptamine (7434) .............. Dimethyltryptamine (7435) ........... Psilocybin (7437) .......................... Psilocyn (7438) ............................. 5-methoxy-N,Ndiisopropyltryptamine (7439). N-ethyl-1-phenylcyclohexylamine (7455). 1-(1-phenylcyclohexyl)-pyrrolidine (7458). 1-[1-(2-thienyl)-cyclohexyl]-piperidine (7470). Dihydromorphine (9145) ............... Normorphine (9313) ..................... Methamphetamine (1105) ............ VerDate Mar<15>2010 21:02 Jun 25, 2010 I I I I I I I I I I I I I I I Schedule 1-phenylcyclohexylamine (7460) Phencyclidine (7471). Phenylacetone (8501) .................. 1piperidinocyclohexanecarbonitrile (8603). Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Ecgonine (9180) ........................... Meperidine intermediate-B (9233) Noroxymorphone (9668) .............. II II II II II II II II II The company plans to manufacture high purity drug standards used for analytical application only in clinical, toxicological, and forensic laboratories. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than August 27, 2010. Dated: June 17, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–15517 Filed 6–25–10; 8:45 am] I BILLING CODE 4410–09–P I I I I I I I I I I I I I I DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this is notice that on April 27, 2010, Research Triangle Institute, Kenneth H. Davis Jr., Hermann Building, East Institute Drive, P.O. Box 12194, Research Triangle, North Carolina 27709, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic classes of controlled substances listed in schedules I and II: I Drug I 1-(1-Phenylcyclohexyl)pyrrolidine (7458). 1-[1-(2Thienyl)cyclohexyl]piperidine (7470). I I II Jkt 220001 PO 00000 Frm 00053 Fmt 4703 Schedule Sfmt 4703 I I Drug 1-[1-(2Thienyl)cyclohexyl]pyrrolidine (7473). 1-Methyl-4-phenyl-4propionoxypiperidine (9661). 1-(2-Phenylethyl)-4-phenyl-4acetoxypiperidine (9663). 2,5-Dimethoxy-4-(n)propylthiophenethylamine (7348). 2,5-Dimethoxy-4ethylamphetamine (7399). 2,5-Dimethoxyamphetamine (7396). 3,4,5-Trimethoxyamphetamine (7390). 3,4-Methylenedioxyamphetamine (7400). 3,4Methylenedioxymethamphetamine (7405). 3,4-Methylenedioxy-Nethylamphetamine (7404). 3-Methylfentanyl (9813) ................ 3-Methylthiofentanyl (9833) .......... 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 4-Methylaminorex (cis isomer) (1590). 4-Methoxyamphetamine (7411) ... 5-Methoxy-3,4methylenedioxyamphetamine (7401). 5-Methoxy-N,Ndiisopropyltryptamine (7439). Acetorphine (9319) ....................... Acetyl-alpha-methylfentanyl (9815). Acetyldihydrocodeine (9051) ........ Acetylmethadol (9601) ................. Allylprodine (9602) ....................... Alphacetylmethadol except levoalphacetylmethadol (9603). Alpha-ethyltryptamine (7249) ....... Alphameprodine (9604) ................ Alphamethadol (9605) .................. Alpha-methylfentanyl (9814) ........ Alpha-methylthiofentanyl (9832) ... Alpha-methyltryptamine (7432) .... Aminorex (1585) ........................... Benzethidine (9606) ..................... Benzylmorphine (9052) ................ Betacetylmethadol (9607) ............ Beta-hydroxy-3-methylfentanyl (9831). Beta-hydroxyfentanyl (9830) ........ Betameprodine (9608) .................. Betamethadol (9609) .................... Betaprodine (9611) ....................... Bufotenine (7433) ......................... Cathinone (1235) .......................... Clonitazene (9612) ....................... Codeine methylbromide (9070) .... Codeine-N-Oxide (9053) .............. Cyprenorphine (9054) .................. Desomorphine (9055) ................... Dextromoramide (9613) ............... Diampromide (9615) ..................... Diethylthiambutene (9616) ........... E:\FR\FM\28JNN1.SGM 28JNN1 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I

Agencies

[Federal Register Volume 75, Number 123 (Monday, June 28, 2010)]
[Notices]
[Page 36681]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-15517]



[[Page 36681]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Application

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 29, 2010, Alltech 
Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methcathinone (1237).......................  I
N-ethylamphetamine (1475)..................  I
N,N-dimethylamphetamine (1480).............  I
4-methylaminorex (cis isomer) (1590).......  I
Alpha-ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
4-methylaminorex (cis isomer) (1590).......  I
Alpha-ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
2,5-dimethoxy-4-(n)-                         I
 propylthiophenethylamine (7348).
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
4-bromo-2,5-dimethoxy-amphetamine (7391)...  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).  I
4-methyl-2,5-dimethoxy-amphetamine (7395)..  I
2,5-dimethoxyamphetamine (7396)............  I
2,5-dimethoxy-4-ethylamphetamine (7399)....  I
3,4-methylenedioxy amphetamine (7400)......  I
N-hydroxy-3,4-methylenedioxyamphetamine      I
 (7402).
3,4-methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-methylenedioxymethamphetamine (MDMA)     I
 (7405).
4-methoxyamphetamine (7411)................  I
Alpha-methyltryptamine (7432)..............  I
Bufotenine (7433)..........................  I
Diethyltryptamine (7434)...................  I
Dimethyltryptamine (7435)..................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
5-methoxy-N,N-diisopropyltryptamine (7439).  I
N-ethyl-1-phenylcyclohexylamine (7455).....  I
1-(1-phenylcyclohexyl)-pyrrolidine (7458)..  I
1-[1-(2-thienyl)-cyclohexyl]-piperidine      I
 (7470).
Dihydromorphine (9145).....................  I
Normorphine (9313).........................  I
Methamphetamine (1105).....................  II
1-phenylcyclohexylamine (7460)               II
 Phencyclidine (7471).
Phenylacetone (8501).......................  II
1-piperidinocyclohexanecarbonitrile (8603).  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Ecgonine (9180)............................  II
Meperidine intermediate-B (9233)...........  II
Noroxymorphone (9668)......................  II
------------------------------------------------------------------------

    The company plans to manufacture high purity drug standards used 
for analytical application only in clinical, toxicological, and 
forensic laboratories.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than August 27, 2010.

    Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-15517 Filed 6-25-10; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.